|
Eine Ebene nach oben |
Gruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 4
2020
Geng, Xiaocong; Babayeva, Lamiya; Walch, Axel; Aubele, Michaela; Gross, Eva; Kiechle, Marion; Bronger, Holger; Dreyer, Tobias; Magdolen, Viktor und Dorn, Julia
(2020):
High levels of KLK7 protein expression are related to a favorable prognosis in triple-negative breast cancer patients.
In: American Journal of Cancer Research, Bd. 10, Nr. 6: S. 1785-1792
2018
Absmaier, Magdalena; Napieralski, Rudolf; Schuster, Tibor; Aubele, Michaela; Walch, Axel; Magdolen, Viktor; Dorn, Julia; Gross, Eva; Harbeck, Nadia; Noske, Aurelia; Kiechle, Marion und Schmitt, Manfred
(2018):
PITX2 DNA-methylation predicts response to anthracycline-based adjuvant chemotherapy in triple-negative breast cancer patients.
In: International Journal of Oncology, Bd. 52, Nr. 3: S. 755-767
2016
Gross, Eva; Tinteren, Harm van; Li, Zhou; Raab, Sandra; Meul, Christina; Avril, Stefanie; Laddach, Nadja; Aubele, Michaela; Propping, Corinna; Gkazepis, Apostolos; Schmitt, Manfred; Meindl, Alfons; Nederlof, Petra M.; Kiechle, Marion und Lips, Esther H.
(2016):
Identification of BRCA1-like triple-negative breast cancers by quantitative multiplex-ligation-dependent probe amplification (MLPA) analysis of BRCA1-associated chromosomal regions: a validation study.
In: BMC Cancer
16:811
[PDF, 761kB]
Huber, Michaela C.; Mall, Rebecca; Braselmann, Herbert; Feuchtinger, Annette; Molatore, Sara; Lindner, Katrin; Walch, Axel; Gross, Eva; Schmitt, Manfred; Falkenberg, Natalie und Aubele, Michaela
(2016):
uPAR enhances malignant potential of triple-negative breast cancer by directly interacting with uPA and IGF1R.
In: BMC Cancer
16:615
[PDF, 2MB]